Filing Details

Accession Number:
0001209191-13-012859
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-01 16:55:19
Reporting Period:
2013-02-27
Filing Date:
2013-03-01
Accepted Time:
2013-03-01 16:55:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1100962 Endo Health Solutions Inc. ENDP Pharmaceutical Preparations (2834) 134022871
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1516098 Daniel Rudio C/O Endo Health Solutions Inc.
1400 Atwater Drive
Malvern PA 19355
Vice President, Controller No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value, $0.01 Per Share Disposition 2013-02-27 448 $29.88 526 No 4 S Direct
Common Stock, Par Value, $0.01 Per Share Disposition 2013-02-27 322 $29.88 526 No 4 S Direct
2010 Stock Incentive Plan Restricted Stock Units (Rsu) Acquisiton 2013-02-27 2,727 $0.00 2,727 No 4 A Direct
Common Stock, Par Value, $0.01 Per Share Disposition 2013-02-28 520 $30.91 526 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock 2010 Stock Incentive Plan Stock Options Acquisiton 2013-02-27 3,012 $0.00 3,012 $30.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,012 2020-02-27 No 4 A Direct
Footnotes
  1. This sale was made pursuant to an election made by Mr. Rudio in September 2012 to sell all shares upon vesting.
  2. $29.88 represents the average price of the shares sold on February 27, 2013.
  3. The remainder of Mr. Rudio's beneficially owned shares are a result of common stock purchases in the ordinary course of business through the Company's qualified Employee Stock Purchase Plan (ESPP).
  4. Upon each vesting date, each vested restricted stock unit automatically converts into one (1) share of Endo Health Solutions Inc. common stock. These restricted stock units (RSUs) are generally exercisable 25% per year on each of February 27, 2014, February 27, 2015, February 27, 2016 and February 27, 2017. Upon vesting, we consider the underlying RSUs to be expired.
  5. These securities were granted to Mr. Rudio in consideration of his services as the Principal Accounting Officer of Endo Health Solutions Inc.
  6. $30.91 represents the average price of the shares sold on February 28, 2013.
  7. These stock options are generally exercisable 25% per year on each of February 27, 2014, February 27, 2015, February 27, 2016 and February 27, 2017.